Immediate Impact
3 from Science/Nature 63 standout
Citing Papers
Artificial intelligence in drug development
2025 Standout
A visual-language foundation model for computational pathology
2024 Standout
Works of Patrick Julier being referenced
Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial
2016
Phase III Randomized Trial Assessing Rofecoxib in the Adjuvant Setting of Colorectal Cancer: Final Results of the VICTOR Trial
2010
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Patrick Julier | 155 | 87 | 19 | 69 | 9 | 290 | |
| C. Wei | 132 | 49 | 30 | 124 | 8 | 296 | |
| Jenny Mao | 74 | 41 | 25 | 65 | 10 | 294 | |
| Sara Lewis | 37 | 41 | 36 | 30 | 11 | 298 | |
| Cui-Hong Zhu | 93 | 34 | 16 | 33 | 12 | 291 | |
| M Bennetts | 72 | 21 | 13 | 104 | 8 | 289 | |
| Jeffrey Lombardo | 164 | 37 | 2 | 108 | 11 | 326 | |
| Liv Marit Dørum | 170 | 30 | 3 | 39 | 9 | 228 | |
| Alessandro Anastasi | 98 | 84 | 33 | 62 | 8 | 207 | |
| Simon Grumett | 116 | 30 | 5 | 100 | 12 | 216 | |
| Sung‐Su Yun | 89 | 28 | 3 | 63 | 16 | 310 |
All Works
Login with ORCID to disown or claim papers
Loading papers...